Zobrazeno 1 - 10
of 63
pro vyhledávání: '"Byung Chul Cho"'
Autor:
Ji Hyeon Joo, Young Seok Kim, Byung Chul Cho, Chi Young Jeong, Won Park, Hak Jae Kim, Won Sup Yoon, Mee Sun Yoon, Ji-Yoon Kim, Jin Hwa Choi, Youngmin Choi, Joo-Young Kim
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173476 (2017)
To determine inter-observer variability in target volume definition of cervical cancer in radical and adjuvant radiotherapy (RT) settings.Eight physicians contoured CTVs of 2 patients underwent definitive and postoperative RT. Each volume was analyze
Externí odkaz:
https://doaj.org/article/507d2533f55c41c7a049ea385faa6992
Autor:
Byung Chul Cho
Publikováno v:
EPISTÉMÈ. 25:185-203
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::009fd6f9961cd824d5af3b3c7986cae2
https://doi.org/10.38119/cacs.2021.25.8
https://doi.org/10.38119/cacs.2021.25.8
Autor:
Yeona Cho, Yejin Kim, Ibrahim Chamseddine, Won Hee Lee, Hye Ryun Kim, Ik Jae Lee, Min Hee Hong, Byung Chul Cho, Chang Geol Lee, Seungryong Cho, Jin Sung Kim, Hong In Yoon, Clemens Grassberger
Publikováno v:
Radiother Oncol
PURPOSE: We investigated the dynamics of lymphocyte depletion and recovery during and after definitive concurrent chemoradiotherapy (CCRT), dose to which structures is correlated to them, and how they affect the prognosis of stage III non-small cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8427c1a6a1b44489ebcab507142f1ce8
https://europepmc.org/articles/PMC9036741/
https://europepmc.org/articles/PMC9036741/
Autor:
Yun-jeong Choe, Eunyoung Kim, Jooyeon Oh, Miran Jang, Weixan Fu, Hanna Lee, Minho Chung, Kyung-Ho Pyo, Chung-Bong Synn, Sora Kim, Yohan Yang, Ahyeon Kim, Byung Chul Cho, Han Sang Kim, Sangwoo Kim, Beatriz Carreno, Jee Ye Kim, Soonmyung Paik
BackgroundThe development of personalized neoantigen-based therapeutic cancer vaccines relies on computational algorithm-based pipelines. One of the critical issues in the pipeline is obtaining higher positive predictive value (PPV) performance, i.e.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17137b8d2b1ff539d3e5ba0025cd5b67
https://doi.org/10.1101/2021.12.12.472304
https://doi.org/10.1101/2021.12.12.472304
Autor:
Yun-jeong Choe, Eunyoung Kim, Jooyeon Oh, Miran Jang, Weixan Fu, Hann Lee, Minho Chung, Kyung-Ho Pyo, Chung-Bong Synn, Sora Kim, Yohan Yang, Ahyeon Kim, Byung Chul Cho, Han Sang Kim, Sangwoo Kim, Beatriz Carreno, Jee Ye Kim, Soonmyung Paik
Whether estrogen receptor-positive (ER+) breast cancer (BC) can be a target for therapeutic neoepitope vaccination is not clear due to its low mutation burden. We tested the immunogenicity of predicted neoepitopes from exome and RNA-seq data from thr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e2b98ba2bd69fd8f9d372c8beb8de14
https://doi.org/10.21203/rs.3.rs-1041598/v1
https://doi.org/10.21203/rs.3.rs-1041598/v1
Publikováno v:
The Journal of Korean Studies. :403-436
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd4a9630312d51cb2fc2a7d5475f7e10
https://doi.org/10.17790/kors.2017..62.403
https://doi.org/10.17790/kors.2017..62.403
Autor:
Yang Gun Suh, Yong Chan Lee, Byung Chul Cho, Chang Geol Lee, Sung Kwan Shin, Sang Kil Lee, Hyun-Ju Kim
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Purpose The correlation between radiation dose and loco-regional control (LRC) was evaluated in patients with stage II-III esophageal cancer treated with definitive concurrent chemoradiotherapy (CRT). Materials and Methods Medical records of 236 stag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a008c92848e0c100d1db9bfd60fb0976
https://doi.org/10.4143/crt.2016.354
https://doi.org/10.4143/crt.2016.354
Autor:
Daniel W. Bowles, D. Tosi, Anna F. Farago, B. Simmons, Luis Paz-Ares, Darren Sigal, Marwan Fakih, Lyudmila Bazhenova, Stephen V. Liu, Conor E. Steuer, Ann M. Johnson, Edna Chow-Maneval, Paul Conkling, Takashi Seto, Collin M. Blakely, Ignacio Garrido-Laguna, Tobias Overbeck, Susan Eng, Pilar Garrido, Salvatore Siena, Herbert H. Loong, Thomas John, Alice T. Shaw, Minal A. Barve, George D. Demetri, Byung Chul Cho, Robert C. Doebele, Alexander Drilon, Young Kwang Chae, Na Cui, Benjamin Besse, Elizabeth Fox, Todd Riehl, Gary L Buchschacher, Sant P. Chawla, Jorge Nieva, John C. Krauss, Timothy R. Wilson
Publikováno v:
Lancet Oncol
The Lancet. Oncology, vol 21, iss 2
The Lancet. Oncology, vol 21, iss 2
Summary Background Entrectinib is a potent inhibitor of tropomyosin receptor kinase (TRK) A, B, and C, which has been shown to have anti-tumour activity against NTRK gene fusion-positive solid tumours, including CNS activity due to its ability to pen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc08dd7f4766300f7a3a6b0658af417c
https://pubmed.ncbi.nlm.nih.gov/34592190
https://pubmed.ncbi.nlm.nih.gov/34592190
Autor:
Byung Chul Cho
Publikováno v:
Journal of Broadcast Engineering. 21:704-713
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::170d0db84c33c51eab535d8b928b3705
https://doi.org/10.5909/jbe.2016.21.5.704
https://doi.org/10.5909/jbe.2016.21.5.704
Autor:
Byung-chul Cho, Jin-young Choi
Publikováno v:
Journal of Internet Computing and Services. 17:91-99
A security system in Android OS adopts sandbox and an permission model. In particular, the permission model operates the confirmation of installation time and all-or-nothing policy. Accordingly, the Android OS requires a user agreement for permission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b9f0564bc583930202c2be6b787a23d
https://doi.org/10.7472/jksii.2016.17.1.91
https://doi.org/10.7472/jksii.2016.17.1.91